Ibalizumab-uiyk (Trogarzo) for multidrug-resistant HIV

Med Lett Drugs Ther. 2018 Apr 23;60(1545):68-69.
No abstract available

Keywords: NNRTIs; adverse effects; dosage; efficacy; pregnancy; protease inhibitors; safety.

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / economics
  • Drug Costs
  • Drug Interactions
  • Drug Resistance, Multiple, Viral*
  • HIV Fusion Inhibitors / administration & dosage*
  • HIV Fusion Inhibitors / adverse effects
  • HIV Fusion Inhibitors / economics
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / drug effects*
  • HIV-1 / immunology
  • HIV-1 / pathogenicity
  • Host-Pathogen Interactions
  • Humans
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • HIV Fusion Inhibitors
  • ibalizumab